Dian Diagnostics Group Co., Ltd. – Corporate News

Trading Overview (as of 08:38 AM Central Europe, Friday 23 Feb 2026)

ItemValue
Current priceCNY 21.56
24‑hour change0 % (flat)
Current supply651.2 million shares
Market capitalizationCNY 13.8 billion
24‑hour volumeCNY 1.3 billion
1‑month change+0.43 %
200‑day simple moving averageCNY 18.97
52‑week highCNY 33.3 (14 Jan 2026)
52‑week lowCNY 14.48 (16 Dec 2025)
Stock24‑hour changeCurrent priceMarket capitalizationP/E ratio
Wuhu Foresight (301529.SZ)0 % (flat)CNY 158.01CNY 16.5 billion119.76
Shenglan (300843.SZ)0 % (flat)CNY 94.52CNY 16.3 billion136.03
Sf‑H (6936.HK)–1.7 %HKD 28.5HKD 19.1 billion11.08
Chagee (CHA)+3.77 %USD 12.46USD 2.5 billion–
Shanghai Por (600018.SS)0 % (flat)CNH 5.37CNH 17.6 billion9.07

Company Profile

  • Name: Dian Diagnostics Group Co., Ltd.
  • Business: Independent medical laboratory services in China.
  • Laboratories: Approximately 31 franchised facilities.
  • Clients: Serves about 12,000 medical institutions.
  • Collaborations: Agreement with Foundation Medicine, Inc. and F. Hoffmann‑La Roche Ltd. to integrate comprehensive genomic profiling assays into patient care in mainland China.
  • History: Formerly Zhejiang DIAN Diagnostics Co., Ltd.; rebranded in November 2017.
  • Founded: 2001.
  • Headquarters: Hangzhou, China.
  • Website: www.dazd.cn
  • Listing: Shenzhen Stock Exchange (symbol 300244.SZ).
  • IPO: 19 July 2011.